닥소 (DXR) 주가

닥소(DXR)는 NAS에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $11.45 (-1.55%), 시가총액 $66.20M, PER 6.93, 52주 범위 $7.74 ~ $14.75.

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

핵심 지표

• 현재가: $11.45 (-1.55%)
• 시가총액: $66.20M
• PER (주가수익비율): 6.93
• 52주 최저~최고: $7.74 ~ $14.75
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NAS

닥소의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

닥소 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (4.5 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.26

자주 묻는 질문